PEDRO PIEDRA to Dose-Response Relationship, Drug
This is a "connection" page, showing publications PEDRO PIEDRA has written about Dose-Response Relationship, Drug.
Connection Strength
0.029
-
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study. J Med Chem. 2015 Feb 26; 58(4):1630-43.
Score: 0.022
-
Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. J Infect Dis. 1998 May; 177(5):1394-7.
Score: 0.007